Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-07-03 @ 7:56 AM
Study NCT ID:
NCT05627960
Status:
RECRUITING
Last Update Posted:
2022-11-28
First Post:
2022-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Sponsor:
A&G Pharmaceutical Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GCC1950
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |